Vendis Capital seals €290m Sylphar sale to EQT's Karo Pharma | Private Equity Insights
Christoffer Lorenzen email address & phone number | Karo Healthcare Chief Executive Officer, CEO contact information - RocketReach
Karo Pharma Adds VMS With Deal For Belgium's Sylphar :: HBW Insight
Karo Pharma switches EMEA media agency | Campaign US
Karo Pharma acquires Trimb AB - European Biotechnology
Fuad Sawaya on LinkedIn: Karo Pharma to Acquire E45 Brand from Reckitt
Euro Results Round-Up: Karo Pharma And Recordati Post Double-Digit Gains :: HBW Insight
PharmaBoardroom - Karo Pharma
Dansker starter i ny toppost i svensk vækstvirksomhed: "En gammel drøm" — MedWatch
EpiEndo Pharmaceuticals Appoints Maria Bech as New Chief Executive Officer to Support Move into Clinical Development | Business Wire
Reckitt announces proposed sale of E45 to Karo Pharma
Annual Report 2018
Christoffer Lorenzen - Chief Executive Officer @ Karo Healthcare - Crunchbase Person Profile
Karo Pharma says Chairman Anders Lonner has died, Health News, ET HealthWorld
Karo profile
Reckitt to sell E45 skincare brand to Karo Pharma for $268 million
PharmaBoardroom - Christoffer Lorenzen - CEO, Karo Pharma, Sweden
Karo Pharma completes the acquisition of the E45® brand from Reckitt
Pat Smallcombe - Board Member - Karo Healthcare | LinkedIn
Vendis Capital | Robin List and Vendis Capital sell their stake in Sylphar to Karo Pharma
Anna Hale appointed Chief Marketing Officer at Karo Pharma
Avista and Karo Pharma Sign Definitive Trimb Acquisition Agreement
He is the new CEO of Karo Pharma - Nordic Life Science – the leading Nordic life science news service
Karo Pharma Completes the Acquisition of the E45® Brand from Reckitt | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
